{
  "FBS": {
    "Normal": {
      "Range": [70, 99],
      "Age": {
        "Baby (0-2 years)": "N/A",
        "Child (3-12 years)": "N/A",
        "Young Adult (20-35 years)": "70–99 mg/dL",
        "Adult (36-64 years)": "70–99 mg/dL",
        "Senior (65+ years)": "70–99 mg/dL"
      },
      "Sex": {
        "Male": "70–99 mg/dL",
        "Female": "70–99 mg/dL"
      },
      "Medication": "None. Continue balanced diet and regular exercise.",
      "Dosage": {
        "Standard": "Not applicable."
      },
      "Treatment": "Daily maintenance",
      "Reason": [
        "A fasting blood sugar between 70 and 99 mg/dL reflects normal glucose metabolism.",
        "This level is associated with a low risk of diabetes and cardiovascular complications."
      ],
      "Conclusion": "Fasting blood sugar is within normal limits. Maintain current lifestyle to sustain optimal glucose control."
    },
    "Prediabetes": {
      "Range": [100, 125],
      "Age": {
        "Baby (0-2 years)": "Not applicable",
        "Child (3-12 years)": "Not applicable",
        "Young Adult (20-35 years)": "100–125 mg/dL; consider early intervention",
        "Adult (36-64 years)": "100–125 mg/dL; lifestyle changes are imperative",
        "Senior (65+ years)": "100–125 mg/dL; initiate careful monitoring and lifestyle adjustments"
      },
      "Sex": {
        "Male": "100–125 mg/dL; assess for insulin resistance",
        "Female": "100–125 mg/dL; assess for insulin resistance"
      },
      "Medication": "Lifestyle modification; consider metformin if needed.",
      "Dosage": {
        "Young Adult (20-35 years)": "Metformin 500 mg twice daily with meals, titrate as needed.",
        "Adult (36-64 years)": "Metformin 500 mg three times daily with meals; adjust based on response.",
        "Senior (65+ years)": "Metformin 500 mg twice daily with meals, starting at the lowest dose with renal monitoring."
      },
      "Treatment": "As treated",
      "Reason": [
        "Fasting blood sugar in the 100–125 mg/dL range indicates impaired fasting glucose and increased risk for type 2 diabetes.",
        "Early intervention can prevent or delay progression to overt diabetes."
      ],
      "Conclusion": "Fasting blood sugar is in the prediabetic range. Emphasize intensive lifestyle modifications and consider pharmacologic intervention if needed."
    },
    "Diabetes": {
      "Range": [126, null],
      "Age": {
        "Baby (0-2 years)": "Not applicable",
        "Child (3-12 years)": "Requires pediatric endocrinology evaluation",
        "Young Adult (20-35 years)": "≥126 mg/dL; requires prompt management",
        "Adult (36-64 years)": "≥126 mg/dL; confirm diagnosis and initiate diabetes care plan",
        "Senior (65+ years)": "≥126 mg/dL; treatment should be individualized considering comorbidities"
      },
      "Sex": {
        "Male": "≥126 mg/dL; immediate management indicated",
        "Female": "≥126 mg/dL; immediate management indicated"
      },
      "Medication": "Metformin",
      "Dosage": {
        "Young Adult (20-35 years)": "Metformin 500 mg twice daily with meals, titrate as needed.",
        "Adult (36-64 years)": "Metformin 500 mg three times daily with meals; adjust dose based on response.",
        "Senior (65+ years)": "Metformin 500 mg twice daily with meals, start at low dose with renal monitoring."
      },
      "Treatment": "As treated",
      "Reason": [
        "A fasting blood sugar ≥126 mg/dL is diagnostic for diabetes, indicating significant impairment in glucose regulation.",
        "Early and aggressive management is needed to reduce the risk of microvascular and macrovascular complications."
      ],
      "Conclusion": "The fasting blood sugar level indicates diabetes. Initiate comprehensive diabetes management with lifestyle changes and appropriate pharmacotherapy."
    }
  },
  "BUN": {
    "Range": [7, 20],
    "Age": {
      "Baby (0-2 years)": "7–18 mg/dL",
      "Child (3-12 years)": "7–18 mg/dL",
      "Young Adult (20-35 years)": "7–18 mg/dL",
      "Adult (36-64 years)": "7–20 mg/dL",
      "Senior (65+ years)": "7–20 mg/dL (may vary with renal function)"
    },
    "Sex": {
      "Male": "7–20 mg/dL",
      "Female": "7–20 mg/dL"
    },
    "Medication": "None required.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "Normal BUN indicates adequate kidney filtration and proper hydration."
    ],
    "Conclusion": "BUN is within normal limits. Maintain proper hydration and periodic renal monitoring."
  },
  "Creatinine": {
    "Range": [0.6, 1.3],
    "Age": {
      "Baby (0-2 years)": "0.2–0.5 mg/dL",
      "Child (3-12 years)": "0.3–0.7 mg/dL",
      "Young Adult (20-35 years)": "0.6–1.1 mg/dL",
      "Adult (36-64 years)": "0.6–1.3 mg/dL",
      "Senior (65+ years)": "0.6–1.3 mg/dL (may vary with renal function)"
    },
    "Sex": {
      "Male": "0.6–1.3 mg/dL",
      "Female": "0.5–1.1 mg/dL"
    },
    "Medication": "No medication if normal; consult nephrology if elevated.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "Creatinine within normal limits reflects healthy renal function."
    ],
    "Conclusion": "Creatinine is normal. Continue routine renal function monitoring."
  },
  "Uric Acid": {
    "Range": [3.5, 7.2],
    "Current Level": "7.3 mg/dL",
    "Age": {
      "Baby (0-2 years)": "3.0–6.0 mg/dL",
      "Child (3-12 years)": "3.0–6.0 mg/dL",
      "Young Adult (20-35 years)": "3.5–7.2 mg/dL",
      "Adult (36-64 years)": "3.5–7.2 mg/dL",
      "Senior (65+ years)": "3.5–7.2 mg/dL"
    },
    "Sex": {
      "Male": "3.5–7.2 mg/dL",
      "Female": "2.6–6.0 mg/dL"
    },
    "Medication": "Allopurinol",
    "Dosage": {
      "Young Adult (20-35 years)": "Start at 100 mg once daily; titrate as needed.",
      "Adult (36-64 years)": "100–300 mg daily; adjust dose according to response and renal function.",
      "Senior (65+ years)": "Start at 100 mg daily with careful monitoring; adjust dose as needed."
    },
    "Treatment": "As treated",
    "Reason": [
      "A uric acid level at the upper limit or slightly above normal increases the risk for gout and renal calculi.",
      "Dietary modification and weight management are also important."
    ],
    "Conclusion": "Uric acid is mildly elevated. Recommend lifestyle changes and initiate allopurinol if clinical symptoms of gout appear."
  },
  "Cholesterol": {
    "Range": [125, 200],
    "Current Level": "186.15 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "125–200 mg/dL",
      "Adult (36-64 years)": "125–200 mg/dL",
      "Senior (65+ years)": "125–200 mg/dL"
    },
    "Sex": {
      "Male": "125–200 mg/dL",
      "Female": "125–200 mg/dL"
    },
    "Medication": "Atorvastatin",
    "Dosage": {
      "Young Adult (20-35 years)": "Atorvastatin 10 mg once daily; adjust based on LDL goals.",
      "Adult (36-64 years)": "Atorvastatin 20–40 mg once daily; titrate as needed.",
      "Senior (65+ years)": "Atorvastatin 10–20 mg once daily; consider comorbidities."
    },
    "Treatment": "As treated",
    "Reason": [
      "Cholesterol within this range is generally desirable; however, overall cardiovascular risk factors must be assessed."
    ],
    "Conclusion": "Cholesterol is within normal limits. Advise maintaining a heart‑healthy diet and regular exercise."
  },
  "Triglycerides": {
    "Range": [0, 150],
    "Current Level": "186.36 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "0–150 mg/dL",
      "Adult (36-64 years)": "0–150 mg/dL",
      "Senior (65+ years)": "0–150 mg/dL"
    },
    "Sex": {
      "Male": "0–150 mg/dL",
      "Female": "0–150 mg/dL"
    },
    "Medication": "Fenofibrate",
    "Dosage": {
      "Young Adult (20-35 years)": "Fenofibrate 145 mg once daily.",
      "Adult (36-64 years)": "Fenofibrate 145 mg once daily.",
      "Senior (65+ years)": "Fenofibrate 145 mg once daily; adjust if necessary."
    },
    "Treatment": "As treated",
    "Reason": [
      "Elevated triglycerides are associated with increased cardiovascular risk and may indicate metabolic syndrome."
    ],
    "Conclusion": "Triglyceride levels are elevated. Recommend dietary modifications, increased physical activity, and consider fibrate therapy if levels persist."
  },
  "VLDL": {
    "Range": [5, 40],
    "Current Level": "35.77 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "5–40 mg/dL",
      "Adult (36-64 years)": "5–40 mg/dL",
      "Senior (65+ years)": "5–40 mg/dL"
    },
    "Sex": {
      "Male": "5–40 mg/dL",
      "Female": "5–40 mg/dL"
    },
    "Medication": "Lifestyle modification; statin therapy may be considered if indicated.",
    "Dosage": {
      "Standard": "Not applicable specifically for VLDL."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "Slightly elevated VLDL can contribute to atherogenesis and cardiovascular risk."
    ],
    "Conclusion": "VLDL is near the upper limit of normal. Recommend dietary fat reduction, weight management, and regular exercise."
  },
  "HDL": {
    "Range": [40, 65],
    "Current Level": "35.77 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "40–65 mg/dL",
      "Adult (36-64 years)": "40–65 mg/dL",
      "Senior (65+ years)": "40–65 mg/dL"
    },
    "Sex": {
      "Male": "40–65 mg/dL",
      "Female": "40–65 mg/dL"
    },
    "Medication": "Niacin",
    "Dosage": {
      "Young Adult (20-35 years)": "Niacin 500 mg once daily, titrate gradually if tolerated.",
      "Adult (36-64 years)": "Niacin 500 mg twice daily with meals.",
      "Senior (65+ years)": "Niacin 500 mg once daily with food."
    },
    "Treatment": "As treated",
    "Reason": [
      "Low HDL is a risk factor for cardiovascular disease; improving HDL can reduce risk."
    ],
    "Conclusion": "HDL is below target. Emphasize increased physical activity, dietary changes, and consider niacin therapy if lifestyle modifications are insufficient."
  },
  "LDL": {
    "Range": [0, 150],
    "Current Level": "114.62 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "0–150 mg/dL",
      "Adult (36-64 years)": "0–150 mg/dL",
      "Senior (65+ years)": "0–150 mg/dL"
    },
    "Sex": {
      "Male": "0–150 mg/dL",
      "Female": "0–150 mg/dL"
    },
    "Medication": "Statins (if indicated)",
    "Dosage": {
      "Standard": "If indicated, initiate statin therapy per established guidelines; otherwise, no medication is required."
    },
    "Treatment": "As treated",
    "Reason": [
      "LDL within target range is generally reassuring, but overall cardiovascular risk assessment is essential."
    ],
    "Conclusion": "LDL is acceptable. Continue preventive measures including diet and exercise."
  },
  "CHOL/HDL Ratio": {
    "Range": [0, 4.5],
    "Current Level": "5.2",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "0–4.5",
      "Adult (36-64 years)": "0–4.5",
      "Senior (65+ years)": "0–4.5"
    },
    "Sex": {
      "Male": "0–4.5",
      "Female": "0–4.5"
    },
    "Medication": "Lifestyle modifications; consider statin therapy if indicated.",
    "Dosage": {
      "Standard": "Refer to statin dosing guidelines if therapy is initiated."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "An elevated CHOL/HDL ratio is an independent predictor of cardiovascular events."
    ],
    "Conclusion": "The CHOL/HDL ratio is elevated. Recommend aggressive lifestyle modifications and consider pharmacologic therapy after comprehensive cardiovascular risk assessment."
  },
  "SGPT/ALT": {
    "Range": [7, 56],
    "Current Level": "42 U/L",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "7–56 U/L",
      "Adult (36-64 years)": "7–56 U/L",
      "Senior (65+ years)": "7–56 U/L"
    },
    "Sex": {
      "Male": "7–56 U/L",
      "Female": "7–56 U/L"
    },
    "Medication": "Silymarin",
    "Dosage": {
      "Young Adult (20-35 years)": "Silymarin 140 mg three times daily with meals.",
      "Adult (36-64 years)": "Silymarin 140 mg three times daily with meals.",
      "Senior (65+ years)": "Silymarin 140 mg twice daily; adjust based on tolerance."
    },
    "Treatment": "As treated",
    "Reason": [
      "A mild elevation in ALT may indicate transient hepatic stress from diet, alcohol, or medication.",
      "Monitoring and lifestyle modifications can help normalize levels."
    ],
    "Conclusion": "ALT is marginally elevated. Recommend liver‑friendly dietary changes and consider Silymarin supplementation if levels remain high."
  },
  "SGOT/AST": {
    "Range": [10, 40],
    "Current Level": "21 U/L",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "10–40 U/L",
      "Adult (36-64 years)": "10–40 U/L",
      "Senior (65+ years)": "10–40 U/L"
    },
    "Sex": {
      "Male": "10–40 U/L",
      "Female": "10–40 U/L"
    },
    "Medication": "No medication required.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "Normal AST indicates preserved liver and muscle function."
    ],
    "Conclusion": "AST is normal. Continue a balanced diet and regular exercise."
  },
  "HbA1C": {
    "Range": [4.0, 5.6],
    "Current Level": "6.6 %",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "4.0–5.6 %",
      "Adult (36-64 years)": "4.0–5.6 %",
      "Senior (65+ years)": "4.0–5.6 %"
    },
    "Sex": {
      "Male": "4.0–5.6 %",
      "Female": "4.0–5.6 %"
    },
    "Medication": "Metformin",
    "Dosage": {
      "Young Adult (20-35 years)": "Metformin 500 mg twice daily with meals; titrate based on glycemic response.",
      "Adult (36-64 years)": "Metformin 500 mg three times daily with meals; adjust based on renal function and tolerance.",
      "Senior (65+ years)": "Metformin 500 mg twice daily with meals; start low and titrate cautiously."
    },
    "Treatment": "As treated",
    "Reason": [
      "An elevated HbA1C indicates chronic hyperglycemia, increasing the risk for diabetic complications.",
      "Early and aggressive intervention can reduce long‑term complications."
    ],
    "Conclusion": "HbA1C is elevated, suggesting impaired long‑term glycemic control. Intensify lifestyle modifications and consider initiating metformin therapy."
  },
  "Sodium": {
    "Range": [135, 145],
    "Current Level": "137 mEq/L",
    "Age": {
      "Baby (0-2 years)": "135–145 mEq/L",
      "Child (3-12 years)": "135–145 mEq/L",
      "Young Adult (20-35 years)": "135–145 mEq/L",
      "Adult (36-64 years)": "135–145 mEq/L",
      "Senior (65+ years)": "135–145 mEq/L"
    },
    "Sex": {
      "Male": "135–145 mEq/L",
      "Female": "135–145 mEq/L"
    },
    "Medication": "No medication required.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "Sodium within this range confirms proper fluid and electrolyte balance."
    ],
    "Conclusion": "Sodium is normal. Maintain adequate hydration and routine electrolyte monitoring."
  },
  "Potassium": {
    "Range": [3.5, 5.0],
    "Current Level": "4.2 mEq/L",
    "Age": {
      "Baby (0-2 years)": "3.5–5.0 mEq/L",
      "Child (3-12 years)": "3.5–5.0 mEq/L",
      "Young Adult (20-35 years)": "3.5–5.0 mEq/L",
      "Adult (36-64 years)": "3.5–5.0 mEq/L",
      "Senior (65+ years)": "3.5–5.0 mEq/L"
    },
    "Sex": {
      "Male": "3.5–5.0 mEq/L",
      "Female": "3.5–5.0 mEq/L"
    },
    "Medication": "No medication required if within normal limits.",
    "Dosage": {
      "Standard": "Not applicable.",
      "If Hypokalemia": "Oral potassium chloride 20–40 mEq every 8 hours or IV potassium chloride 10–20 mEq per hour (with monitoring)."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "Normal potassium is vital for proper muscle function and nerve conduction."
    ],
    "Conclusion": "Potassium is normal. Continue a balanced diet to sustain electrolyte equilibrium."
  },
  "WBC": {
    "Range": [4.0, 11.0],
    "Current Level": "6.2 x 10^3/μL",
    "Age": {
      "Baby (0-2 years)": "6.0–17.5 x 10^3/μL",
      "Child (3-12 years)": "5.0–13.0 x 10^3/μL",
      "Young Adult (20-35 years)": "4.0–11.0 x 10^3/μL",
      "Adult (36-64 years)": "4.0–11.0 x 10^3/μL",
      "Senior (65+ years)": "4.0–11.0 x 10^3/μL"
    },
    "Sex": {
      "Male": "4.0–11.0 x 10^3/μL",
      "Female": "4.0–11.0 x 10^3/μL"
    },
    "Medication": "No medication required.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "A normal WBC count indicates a properly functioning immune system."
    ],
    "Conclusion": "WBC is within normal limits. No intervention is necessary."
  },
  "Calcium": {
    "Range": [8.5, 10.2],
    "Current Level": "9.4 mg/dL",
    "Age": {
      "Baby (0-2 years)": "8.5–10.5 mg/dL",
      "Child (3-12 years)": "8.5–10.5 mg/dL",
      "Young Adult (20-35 years)": "8.5–10.2 mg/dL",
      "Adult (36-64 years)": "8.5–10.2 mg/dL",
      "Senior (65+ years)": "8.5–10.2 mg/dL"
    },
    "Sex": {
      "Male": "8.5–10.2 mg/dL",
      "Female": "8.5–10.2 mg/dL"
    },
    "Medication": "Calcium supplementation only if a deficiency is documented.",
    "Dosage": {
      "Low Calcium": "Typically 500–1000 mg of elemental calcium daily, divided into 2–3 doses."
    },
    "Treatment": "As treated",
    "Reason": [
      "Calcium is essential for bone health and neuromuscular function.",
      "Adequate levels help prevent osteoporosis and related complications."
    ],
    "Conclusion": "Calcium is normal. Supplement only if deficiency is confirmed."
  },
  "Magnesium": {
    "Range": [1.7, 2.2],
    "Current Level": "2.0 mg/dL",
    "Age": {
      "Baby (0-2 years)": "1.5–2.5 mg/dL",
      "Child (3-12 years)": "1.5–2.5 mg/dL",
      "Young Adult (20-35 years)": "1.7–2.2 mg/dL",
      "Adult (36-64 years)": "1.7–2.2 mg/dL",
      "Senior (65+ years)": "1.7–2.2 mg/dL"
    },
    "Sex": {
      "Male": "1.7–2.2 mg/dL",
      "Female": "1.7–2.2 mg/dL"
    },
    "Medication": "Magnesium supplementation if levels are low.",
    "Dosage": {
      "Low Magnesium": "200–400 mg daily, adjusted based on clinical response."
    },
    "Treatment": "As treated",
    "Reason": [
      "Magnesium is critical for muscle and nerve function and energy metabolism.",
      "Normal levels help prevent neuromuscular and cardiovascular issues."
    ],
    "Conclusion": "Magnesium is within normal limits. Ensure adequate dietary intake."
  },
  "Phosphorus": {
    "Range": [2.5, 4.5],
    "Current Level": "3.2 mg/dL",
    "Age": {
      "Baby (0-2 years)": "3.5–6.0 mg/dL",
      "Child (3-12 years)": "3.0–5.0 mg/dL",
      "Young Adult (20-35 years)": "2.5–4.5 mg/dL",
      "Adult (36-64 years)": "2.5–4.5 mg/dL",
      "Senior (65+ years)": "2.5–4.5 mg/dL"
    },
    "Sex": {
      "Male": "2.5–4.5 mg/dL",
      "Female": "2.5–4.5 mg/dL"
    },
    "Medication": "Phosphorus supplementation only if a deficiency is confirmed.",
    "Dosage": {
      "Low Phosphorus": "Dosage should be individualized based on deficiency severity."
    },
    "Treatment": "As treated",
    "Reason": [
      "Phosphorus is vital for cellular energy and bone mineralization.",
      "Normal levels ensure adequate metabolic function."
    ],
    "Conclusion": "Phosphorus is within normal limits. No supplementation is needed."
  },
  "Albumin": {
    "Range": [3.5, 5.0],
    "Current Level": "4.1 g/dL",
    "Age": {
      "Baby (0-2 years)": "3.5–5.5 g/dL",
      "Child (3-12 years)": "3.5–5.0 g/dL",
      "Young Adult (20-35 years)": "3.5–5.0 g/dL",
      "Adult (36-64 years)": "3.5–5.0 g/dL",
      "Senior (65+ years)": "3.5–5.0 g/dL"
    },
    "Sex": {
      "Male": "3.5–5.0 g/dL",
      "Female": "3.5–5.0 g/dL"
    },
    "Medication": "No medication required if albumin is normal.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "Albumin is a marker of liver synthetic function and nutritional status.",
      "Normal levels suggest adequate protein intake and liver health."
    ],
    "Conclusion": "Albumin is within normal limits. Maintain a balanced diet."
  },
  "Bilirubin": {
    "Range": [0.1, 1.2],
    "Current Level": "0.8 mg/dL",
    "Age": {
      "Baby (0-2 years)": "0.1–1.0 mg/dL",
      "Child (3-12 years)": "0.1–1.0 mg/dL",
      "Young Adult (20-35 years)": "0.1–1.2 mg/dL",
      "Adult (36-64 years)": "0.1–1.2 mg/dL",
      "Senior (65+ years)": "0.1–1.2 mg/dL"
    },
    "Sex": {
      "Male": "0.1–1.2 mg/dL",
      "Female": "0.1–1.2 mg/dL"
    },
    "Medication": "No medication required if bilirubin is normal.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Treatment": "Daily maintenance",
    "Reason": [
      "Normal bilirubin indicates effective hepatic clearance and normal red blood cell turnover."
    ],
    "Conclusion": "Bilirubin is normal. No treatment is necessary."
  }
}
